Many patients with acromegaly may do as well on oral octreotide treatment as they do on injectable somatostatin receptor ligands, an industry-sponsored phase 3 trial suggests.
Amryt Pharma: Reicht das? () | aktiencheck de aktiencheck.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aktiencheck.de Daily Mail and Mail on Sunday newspapers.
Cheap UK shares: 1 I am considering right now fool.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.co.uk Daily Mail and Mail on Sunday newspapers.
A flurry of fundraising activity on the small cap market showed no signs of slowing down this week as a stream of AIM-listed firms sought to take advantage of the festive mood and persuade investors to give them an early Christmas present in the form of a cash injection.
At least five companies on the junior market have conducted fundraisings this week across a variety of sectors, with the haul totalling just under £85million.
One of the biggest funding rounds came from rare disease specialist Amryt Pharmaceuticals, which announced that it has raised $40million (£30million) from a collection of leading US biotech investors to fund potential acquisitions and investments in new technologies and businesses.